Dexcom and Abbott are both moving closer to over-the-counter launches of continuous glucose monitoring (CGM) technology. But ...

The recall details that the affected kits contain incorrect concentrations of Ceftriaxone antibiotic in two wells.

Quest Diagnostics has found its path to artificial intelligence in cancer diagnosis through M&A. The Secaucus NJ-based ...

BrioHealth Solutions has received FDA Investigational Device Exemption (IDE) approval to start enrollment in its Innovate clinical trial assessing the effectiveness and safety of the BioVAD System for ...

First-of-its-kind, Esprit BTK Everolimus Eluting Resorbable Scaffold System is designed to keep treat chronic ...

The Burlington, NC-based company has been selected as the winning bidder to acquire Invitae’s assets for $239 million.

The final rule is sure to shake up the diagnostic industry, for better or worse, depending on who you talk to.

Questions about early physician feedback on Intuitive Surgical's da Vinci 5 robot dominated the company's recent earnings ...

Edwards executives seem unbothered by the SMART results. Results from SMART show Medtronic's Evolut Platform surpassed the ...

Graphic featuring a headshot of MD+DI Senior Editor Amanda Pedersen and pull quote from her Pedersen's POV opinion column.

The company is recalling the needles from one batch as it may contain microscopic stainless-steel debris on the inside of the ...

Digital health exploded during and after the COVID-19 pandemic, and with it came some real concerns about data privacy, ...